Publications by authors named "Jessica Ochalek"

Claim this Profile
E
Estimating the Shares of the Value of Branded Pharmaceuticals Accruing to Manufacturers and to Patients in the Thai Healthcare System.
Jessica M Ochalek, Beth Woods, Lapad Pongcharoenyong, Chotika Suwanpanich, Francis Carlo Panlilio

Value Health· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guiding Health Resource Allocation: Using Population Net Health Benefit to Align Disease Burden with Cost Effectiveness for Informed Decision Making.
Megha Rao, Simon Walker, Karl Claxton, Simon Bland, Jessica Ochalek

Appl Health Econ Health Policy· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life implications of plantar ulcers resulting from neuropathic damage caused by leprosy: An analysis from the trial of autologous blood products (TABLE trial) in Nepal.
Naomi Kate Gibbs, Jessica Ochalek, Indra Bahadur Napit, Dilip Shrestha, Pedro Saramago Goncalves

PLoS One· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using economic analysis to inform health resource allocation: lessons from Malawi.
Megha Rao, Dominic Nkhoma, Sakshi Mohan, Pakwanja Twea, Benson Chilima, Jessica Ochalek

Discov Health Syst· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review of the impact of health care expenditure on health outcome measures: implications for cost-effectiveness thresholds.
Mac Ardy Junio Gloria, Montarat Thavorncharoensap, Usa Chaikledkaew, Sitaporn Youngkong, Ammarin Thakkinstian, Jessica Ochalek

Expert Rev Pharmacoecon Outcomes Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimation of Societal Values of Health States Preferences at the National Level for Low- and Middle-Income Countries.
Oscar Espinosa, Michael F Drummond, Luis-Esteban Orozco, Angélica Ordóñez, Daysi Sanmartín, Jessica Ochalek

Value Health Reg Issues· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic evaluation of self-help group interventions for health in LMICs: a scoping review.
Jessica Ochalek, Naomi K Gibbs, Rita Faria, Joydeepa Darlong, Karthikeyan Govindasamy

Health Policy Plan· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges of calculating cost-effectiveness thresholds.
Laura Vallejo-Torres, Karl Claxton, Laura C Edney, Jonathan Karnon, James Lomas, Jessica Ochalek

Lancet Glob Health· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Informing a cost-effectiveness threshold for Saudi Arabia.
Ahmed Hamdan Al-Jedai, James Lomas, Hajer Yousef Almudaiheem, Yazed Sulaiman H Al-Ruthia, Shabab Alghamdi, Jessica Ochalek

J Med Econ· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating the Health Effects of Expansions in Health Expenditure in Indonesia: A Dynamic Panel Data Approach.
Silvia Moler-Zapata, Noémi Kreif, Jessica Ochalek, Andrew J Mirelman, Mardiati Nadjib

Appl Health Econ Health Policy· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supporting a review of the benefits package of the National Health Insurance Scheme in Ghana.
Heleen Vellekoop, Emmanuel Odame, Jessica Ochalek

Cost Eff Resour Alloc· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accounting for country- and time-specific values in the economic evaluation of health-related projects relevant to low- and middle-income countries.
James Lomas, Karl Claxton, Jessica Ochalek

Health Policy Plan· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avoiding Opportunity Cost Neglect in Cost-Effectiveness Analysis for Health Technology Assessment.
James Lomas, Jessica Ochalek, Rita Faria

Appl Health Econ Health Policy· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Empirical Estimates of the Marginal Cost of Health Produced by a Healthcare System: Methodological Considerations from Country-Level Estimates.
Laura C Edney, James Lomas, Jonathan Karnon, Laura Vallejo-Torres, Niek Stadhouders, Jessica Ochalek

Pharmacoeconomics· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant health benefits package design and research prioritisation: development of a new approach and an application to Malawi.
Laetitia Schmitt, Jessica Ochalek, Karl Claxton, Paul Revill, Dominic Nkhoma

BMJ Glob Health· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Valuing health outcomes: developing better defaults based on health opportunity costs.
Jessica Ochalek, Karl Claxton, James Lomas, Kimberly M Thompson

Expert Rev Pharmacoecon Outcomes Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Informing a Cost-Effectiveness Threshold for Health Technology Assessment in China: A Marginal Productivity Approach.
Jessica Ochalek, Haiyin Wang, Yuanyuan Gu, James Lomas, Henry Cutler

Pharmacoeconomics· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What next after GDP-based cost-effectiveness thresholds?
Y-Ling Chi, Mark Blecher, Kalipso Chalkidou, Anthony Culyer, Karl Claxton, Jessica Ochalek

Gates Open Res· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries.
Jessica Ochalek, Kaja Abbas, Karl Claxton, Mark Jit, James Lomas

BMJ Glob Health· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Squaring the cube: Towards an operational model of optimal universal health coverage.
Jessica Ochalek, Gerald Manthalu, Peter C Smith

J Health Econ· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reflecting the Health Opportunity Costs of Funding Decisions Within Value Frameworks: Initial Estimates and the Need for Further Research.
Jessica Ochalek, James Lomas

Clin Ther· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A one stop shop for cost-effectiveness evidence? Recommendations for improving Disease Control Priorities.
Matthias Arnold, Susan Griffin, Jessica Ochalek, Paul Revill, Simon Walker

Cost Eff Resour Alloc· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accounting for Timing when Assessing Health-Related Policies.
Karl Claxton, Miqdad Asaria, Collins Chansa, Julian Jamison, James Lomas, Jessica Ochalek

J Benefit Cost Anal· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating health opportunity costs in low-income and middle-income countries: a novel approach and evidence from cross-country data.
Jessica Ochalek, James Lomas, Karl Claxton

BMJ Glob Health· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supporting the development of a health benefits package in Malawi.
Jessica Ochalek, Paul Revill, Gerald Manthalu, Finn McGuire, Dominic Nkhoma

BMJ Glob Health· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis